Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Diabetes in Schools update

Do you know that the clinical team at Perth Children’s Hospital’s Diabetes Clinic can visit your child’s school to administer glucagon or camp education?

News & Events

Congratulations 2023 Round Two scholarship recipients

The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence (the Centre), announces 2023 Round 2, Honours and PhD scholarships for students dedicated to type 1 diabetes (T1D) research.

News & Events

Sisters strive to succeed

Ashlyn and Kayleigh have much more in common than being siblings – they both excel in their chosen sport and live with type 1 diabetes. We spoke to the sisters about juggling exercise and diabetes.

News & Events

PJs for a day to help sick kids

Eleven-year-old twins Grace and Lilyana Musca had never spent time in hospital when they decided to organise a pyjama day at Hocking Primary School to raise money for sick children earlier this year.

News & Events

Diabetes clinic: We've moved

With a little over a week before outpatient clinics move from Princess Margaret Hospital (PMH) to Perth Children’s Hospital (PCH), now is the time to familiarise yourself with all the information you need to know before you make your first visit.

Research

Cyberbullying and the role of the law in Australian schools: Views of senior officials

Opinions of employees from the education and legal systems, regarding their perceptions of the role of the law and cyberbullying in Australian schools

Research

Use of Hybrid Closed Loop therapy in hypoglycaemia awareness

This study will tell us if the use of a hybrid closed loop system can improve awareness of hypoglycaemia.

WAACHS Regional Profiles

The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.

Research

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

Aboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.

News & Events

Let's Talk Diabetes

A diabetes community session with a focus on healthy children.